Liver NADPH-dependent oxidation of the 5-nitrofurans, FANFT and ANFT, by guinea pig and rat

References

• Astrom A., Maner S., Depierre J. W. Induction of cytochrome P-450 and related drug-metabolizing activities in the livers of different rodent species by 2-acetylaminofluorene or by 3-methylcholanthrene. Biochemical Pharmacology 1986; 35: 2703–2713
   PubMed Web of Science ®Google Scholar
• Battula N., Schut H. A. J., Thorgeirsson S. S. Cytochrome P4501A2 constitutively expressed from transduced DNA mediates metabolic activation and DNA-adduct formation of aromatic amine carcinogens in NIH 3T3 cells. Molecular Carcinogenesis 1991; 4: 407–414
   PubMedGoogle Scholar
• Bryan G. T. Carcinogenesis: A Comprehensive Survey. Raven Press, New York 1986; 1978
   Google Scholar
• Butler M. A., Iwasaki M., Guengerich F. P., Kadlubar F. F. Human cytochrome P-450PA (P-450IA2), the phenacetin 0-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxdiation of carcinogenic arylamines. Proceedings of the National Academy of Sciences, USA 1989; 86: 7696–7700
   PubMed Web of Science ®Google Scholar
• Cohen S. M. Toxicity and carcinogenicity of nitrofurans. Carcinogenesis: A Comprehensive Survey, G. T. Bryan. Raven Press, New York 1978; 171–231
   Google Scholar
• Dawley R. M., Zenser T. V., Mattammal M. B., Lakshmi V. M., Hsu F. F., Davis B. B. Metabolism and disposition of bladder carcinogens in rat and guinea pig: possible mechanism of guinea pig resistance to bladder cancer. Cancer Research 1991; 51: 514–520
   PubMedGoogle Scholar
• Guengerich F. P. Enzymology of rat liver cytochromes P-450. Mammalian Cytochromes P-450, F. P. Guengerich. CRC Press, Boca Raton, FL 1987; 1–54
   Google Scholar
• Hammons G. J., Guengerich F. P., Weis C. C., Beland F. A., Kadlubar F. F. Metabolic oxidation of carcinogenic arylamines by rat, dog, and human hepatic microsomes and by purified flavin-containing and cytochrome P-450 monooxygenases. Cancer Research 1985; 45: 3578–3585
   PubMed Web of Science ®Google Scholar
• Huang S., Gibson G. G. Differential induction of cytochromes P450 and cytochrome P450-dependent arachidonic acid metabolism by 3,4,5,3′,4′-pentachlorobiphenyl in the rat and the guinea pig. Toxicology and Applied Pharmacology 1991; 108: 86–95
   PubMed Web of Science ®Google Scholar
• Kadlubar F. F., Miller J. A., Miller E. C. Hepatic microsomal N-glucuronidation and nucleic acid binding of N-hydroxy arylamines in relation to urinary bladder carcinogenesis. Cancer Research 1977; 37: 805–814
   PubMed Web of Science ®Google Scholar
• Kanazawa Y., Kitada M., Mori T., Inukai Y., Imaoka S., Funae Y., Kamataki T. Ascorbic acid deficiency decreases specific forms of cytochrome P-450 in liver microsomes of guinea pigs. Molecular Pharmacology 1991; 39: 456–460
   PubMed Web of Science ®Google Scholar
• Klemencic J. M., Wang C. Y. Mutagenicity of nitrofurans. Carcinogenesis: A Comprehensive Survey, G. T. Bryan. Raven Press, New York 1978; 99–130
   Google Scholar
• Lakshmi V. M., Mattammal M. B., Spry L. A., Kadlubar F. F., Zenser T. V., Davis B. B. Metabolism and disposition of benzidine in the dog. Carcinogenesis 1990; 11: 139–144
   PubMedGoogle Scholar
• Lower G. M., Jr, Bryan G. T. Enzymatic N-acetylation of carcinogenic aromatic amines by liver cytosol of species displaying different organ susceptibilities. Biochemical Pharmacology 1973; 22: 1581–1588
   PubMed Web of Science ®Google Scholar
• Lower G. M., Jr, Nilsson T., Nelson C. E., Wolf H., Gamsky T. E., Bryan G. T. N-Acetyltransterase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark. Environmental Health Perspectives 1979; 29: 71–79
   PubMed Web of Science ®Google Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Mattammal M. B., Zenser T. V., Davis B. B. Anaerobic metabolism and nuclear binding of the carcinogen 2-amino-4-(5-nitro-2-furyl)thiazole (ANFT). Carcinogenesis (London) 1982; 3: 1339–1344
   PubMedGoogle Scholar
• Mattammal M. B., Zenser T. V., Palmier M. O., Davis B. B. Renal reduced nicotinamide adenine dinucleotide phosphate: cytochrome c reductase-mediated metabolism of the carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]acetamide. Cancer Research 1985; 45: 149–156
   PubMedGoogle Scholar
• Miller E. C., Miller J. A., Enomoto M. The comparative carcinogenicities of 2-acetylaminofluorene and its N-hydroxy metabolite in mice, hamsters, and guinea pigs. Cancer Research 1964; 24: 2018–2031
   PubMed Web of Science ®Google Scholar
• Miranda C. L., Chung W., Reed R. E., Zhao X., Henderson M. C., Wang J-L., Williams D. E., Buhler D. R. Flavin-containing monooxygenase: a major detoxifying enzyme for the pyrrolizidine alkaloid senecionine in guinea pig tissues. Biochemical and Biophysical Research Communications 1991; 178: 546–552
   PubMed Web of Science ®Google Scholar
• Poulsen L. L., Hyslop R. M., Ziegler D. M. S-oxidation of thioureylenes catalyzed by a microsomal flavoprotein mixed-function osidase. Biochemical Pharmacology 1974; 23: 3431–3440
   PubMed Web of Science ®Google Scholar
• Rice J. R., Spry L. A., Zenser T. V., Davis B. B. Effect of peroxidase inhibitors on an in vivo metabolite of the urinary bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats. Cancer Research 1988; 48: 304–309
   PubMedGoogle Scholar
• Sherman W. R., Dickson D. E. 4-(5-Nitro-2-furyl)thiazoles. Journal of Organic Chemistry 1962; 27: 1351–1355
   Google Scholar
• Song B-J, Gelboin H. V., Park S. S., Friedman F. K. Epitope-relatedness and phenotyping of hepatic cytochromes P-450 with monoclonal antibodies. Biochemical Journal 1985; 231: 671–676
   PubMedGoogle Scholar
• Spry L. A., Rubinsein J., Rettke C., Zenser T. V., Davis B. B. Renal metabolic/excretory coupling. American Journal of Physiology 1988; 254: F145–F152
   Google Scholar
• Turesky R. J., Lang N. P., Butler M. A., Teitel C. H., Kadlubar F. F. Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Carcinogenesis 1991; 12: 1839–1845
   PubMed Web of Science ®Google Scholar
• Zenser T. V., Mattammal M. B., Davis B. B. Differential distribution of the mixed-function oxidase activities in rabbit kidney. Journal of Pharmacology and Experimental Therapeutics 1978; 207: 719–725
   PubMed Web of Science ®Google Scholar
• Zenser T. V., Mattammal M. B., Palmier M. O., Davis B. B. Microsomal nitroreductase activity of rabbit kidney and bladder: implications in 5-nitrofuran-induced toxicity. Journal of Pharmacology and Experimental Therapeutics 1981; 219: 735–740
   PubMed Web of Science ®Google Scholar
• Zenser T. V., Palmier M. O., Mattammal M. B., Bolla R. I., Davis B. B. Comparative effects of prostaglandin H synthase-catalyzed binding of two 5-nitrofuran urinary bladder carcinogens. Journal of Pharmacology and Experimental Therapeutics 1983; 227: 139–143
   PubMedGoogle Scholar
• Zenser T. V., Palmier M. O., Mattammal M. B., Davis V. B. Metabolic activation of the carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]acetamide by prostaglandin H. synthase. Carcinogenesis 1984; 5: 1225–1230
   PubMed Web of Science ®Google Scholar
• Ziegler D. M. Flavin-containing monooxygenases: catalytic mechanism and substrate specificities. Drug Metabolosm Reviews 1988; 19: 33–62
   PubMedGoogle Scholar